Palvella Therapeutics (PVLA) EBITDA Margin (QoQ) (2014 - 2024)
Powered by 
Analysis
Palvella Therapeutics (PVLA) EBITDA Margin (QoQ) (2014 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palvella Therapeutics | 2.24 Bn | 1.93 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -434,935.00 |
| Dec 31, 2023 | 109,097.00 |
| Sep 30, 2023 | -7,076.00 |
| Jun 30, 2023 | 78,196.00 |
| Mar 31, 2023 | -57,465.00 |
| Dec 31, 2022 | 2,955.00 |
| Sep 30, 2022 | 10,683.00 |
| Jun 30, 2022 | -26,672.00 |
| Mar 31, 2022 | 6,357.00 |
| Dec 31, 2021 | 33,835.00 |
| Sep 30, 2021 | 4,161.00 |
| Jun 30, 2021 | -47,131.00 |
| Mar 31, 2021 | 62,230.00 |
| Dec 31, 2020 | -21,892.00 |
| Sep 30, 2020 | -40,090.00 |
| Jun 30, 2020 | -1,231.00 |
| Mar 31, 2020 | -2,138.00 |
| Dec 31, 2019 | 1,156.00 |
| Sep 30, 2019 | 21,011.00 |
| Jun 30, 2019 | -10,435.00 |